Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vaccines (Basel) ; 9(2)2021 Feb 04.
Article in English | MEDLINE | ID: mdl-33557082

ABSTRACT

BACKGROUND: Influenza vaccination (IV) and Pneumococcus vaccination (PV) are recommended for patients with cardiometabolic diseases. This study aimed to evaluate the immunization rate of ambulatory cardiometabolic patients during the COVID-19 pandemic in the Americas. METHODS: Electronic surveys were collected from 13 Spanish speaking countries between 15 June and 15 July 2020. RESULTS: 4216 patients were analyzed. Mean age 60 (±15) years and 49% females. Global IV rate was 46.5% and PV 24.6%. Vaccinated patients were older (IV = 63 vs. 58 years; PV = 68 vs. 59, p < 0.01) but without gender difference. Vaccination rates were greater in higher-risk groups (65+, diabetics, heart failure), but not in coronary artery disease patients. In the Southern cone, the rate of IV and PV was approximately double that in the tropical regions of the Americas. In a multivariate model, geographic zone (IV = OR 2.02, PV = OR 2.42, p < 0.001), age (IV = OR 1.023, PV = OR 1.035, p < 0.001), and incomes (IV = OR 1.28, PV = OR 1.58, p < 0.001) were predictors for vaccination. CONCLUSIONS: During the COVID-19 pandemic, ambulatory patients with cardiometabolic diseases from the Americas with no evidence of COVID-19 infection had lower-than-expected rates of IV and PV. Geographic, social, and cultural differences were found, and they should be explored in depth.

2.
Curr Probl Cardiol ; 46(4): 100737, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33412349

ABSTRACT

BACKGROUND: The COVID-19 pandemic's mental health consequences remain unknown. AIM: To assess the mental health status of ambulatory cardiometabolic patients during COVID-19 pandemic lockdown in Spanish speaking Latin American countries. METHODS: Cardiometabolic patients without COVID-19 evidence in 13 Latin American countries answered a survey between June 15th and July 15th, 2020. The Diagnosis Manual of Mental Disorders fifth edition was used to identify the presence of major depressive symptoms. RESULTS: The sample included 4216 patients, 1590 (37.71%; IC95% 36.24-39.19) were considered suffering major depression. Female gender, consuming ≥5 medications day, physical activity <100 minutes weekly, low fruits and vegetables intake, poor treatment adherence, reduced food consumption were independently associated to the presence of major depressive symptoms. CONCLUSIONS: The CorCOVID Latam Psy study showed that one-third of the Latin American Spanish speaking population is suffering from major depressive symptoms during the COVID-19 outbreak.


Subject(s)
COVID-19 , Cardiovascular Diseases/epidemiology , Depression/epidemiology , Depressive Disorder, Major/epidemiology , Diabetes Mellitus/epidemiology , Metabolic Syndrome/epidemiology , Adult , Aged , Cardiovascular Diseases/psychology , Coronary Artery Disease/epidemiology , Coronary Artery Disease/psychology , Depression/psychology , Depressive Disorder, Major/psychology , Diabetes Mellitus/psychology , Diet/statistics & numerical data , Dyslipidemias/epidemiology , Dyslipidemias/psychology , Eating , Exercise/psychology , Female , Fruit , Heart Failure/epidemiology , Heart Failure/psychology , Humans , Hypertension/epidemiology , Hypertension/psychology , Latin America/epidemiology , Male , Mental Health , Metabolic Syndrome/psychology , Middle Aged , SARS-CoV-2 , Sex Factors , Stroke/epidemiology , Stroke/psychology , Surveys and Questionnaires , Treatment Adherence and Compliance/psychology , Treatment Adherence and Compliance/statistics & numerical data , Vegetables
SELECTION OF CITATIONS
SEARCH DETAIL
...